Other TLR4 activators like AS04 (MPL derivative, cervical cancer) and GLA-SE (lymphoma Merkel cell carcinoma) are also studied via preclinical and clinical studies (156–158). This evidence concerns the gene TLR4 and cervical carcinoma.